A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| dNTP Mix | A mixture solution of ultrapure dATP trisodium (1927-31-7), dCTP disodium (102783-51-7), dGTP trisodium (93919-41-6) and dTTP trisodium (18423-43-3). Used in PCR reaction. Synonyms: 4 x 100 mM (dATP, dCTP, dGTP, dTTP); 2'-Deoxyadenosine-5'-triphosphate, Sodium salt; 2'-Deoxycytidine-5'-triphosphate, Sodium salt; 2'-Deoxyguanosine-5'-triphosphate, Sodium salt; 2'-Deoxythymidine-5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: dATP 3Na: C10H13N5Na3O12P3; dCTP 2Na: C9H14N3Na2O13P3; dGTP 3Na: C10H13N5Na3O13P3; dTTP 3Na: C10H14N2Na3O14P3. Mole weight: dATP 3Na: 557.13; dCTP 2Na: 511.12; dGTP 3Na: 573.13; dTTP 3Na: 548.11. |  |
| dNTP Mix / 10 mM | An equimolar (10 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dTTP. Synonyms: Premix of 10 mM dATP, dCTP, dGTP and dTTP; 2'-Deoxyadenosine 5'-triphosphate, Sodium salt; 2'-Deoxycytidine 5'-triphosphate, Sodium salt; 2'-Deoxyguanosine 5'-triphosphate, Sodium salt; 2'-Deoxythymidine 5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: C10H13N5O12P3(Anion); C9H13N3O13P3(Anion); C10H13N5O13P3(Anion); C10H14N2O14P3(Anion). Mole weight: 488.16 (Anion); 464.13 (Anion); 504.16 (Anion); 479.14 (Anion). | |
| dNTP Mix / 25 mM | An equimolar (25 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dTTP. Synonyms: Premix of 25 mM dATP, dCTP, dGTP and dTTP; 2'-Deoxyadenosine 5'-triphosphate, Sodium salt; 2'-Deoxycytidine 5'-triphosphate, Sodium salt; 2'-Deoxyguanosine 5'-triphosphate, Sodium salt; 2'-Deoxythymidine 5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: C10H13N5O12P3(Anion); C9H13N3O13P3(Anion); C10H13N5O13P3(Anion); C10H14N2O14P3(Anion). Mole weight: 488.16 (Anion); 464.13 (Anion); 504.16 (Anion); 479.14 (Anion). | |
| dNTP Mix GCamplifier / 10 mM | Modified dNTP mixture that could be used for amplification of GC-rich sequences. Synonyms: Modified dNTP Mix for amplification of GC-rich sequences. | |
| dNTP Mix incl. dUTP / 10 mM | An equimolar(10 nm) mixture solution of ultrapure dATP, dCTP, dGTP and dUTP. Synonyms: Premix of 10 mM dATP, dCTP, dGTP and 20 mM dUTP; 2'-Deoxyadenosine 5'-triphosphate, Sodium salt; 2'-Deoxycytidine 5'-triphosphate, Sodium salt; 2'-Deoxyguanosine 5'-triphosphate, Sodium salt; 2'-Deoxyuridine 5'-triphosphate, Sodium salt. Grade: ≥ 99 % by HPLC. Molecular formula: C10H13N5O12P3(Anion); C9H13N3O13P3(Anion); C10H13N5O13P3(Anion); C9H12N2O14P3(Anion). Mole weight: 488.16 (Anion); 464.13 (Anion); 504.16 (Anion); 465.12 (Anion). | |
| D-Nva-Ome HCl | D-Nva-Ome HCl. Synonyms: D-Norvaline, methyl ester; (R)-Methyl 2-aminopentanoate; methyl D-norvalinate. CAS No. 21685-17-6. Molecular formula: C6H13NO2. Mole weight: 131.17. | |
| DNV-II impurity 1 | N-[(1R,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic acid 1,1-dimethylethyl ester is an impurity of Darunavir, a human immunodeficiency virus (HIV) protease inhibitor that is used to treat patients with drug-resistant HIV. Synonyms: N-[(1R,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic Acid 1,1-Dimethylethyl Ester. Grade: > 95%. CAS No. 1005324-46-8. Molecular formula: C25H35N3O7S. Mole weight: 521.63. | |
| DNV-II impurity 2 | N-[(1S,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic acid 1,1-dimethylethyl ester is an impurity of Darunavir, a human immunodeficiency virus (HIV) protease inhibitor that is used to treat patients with drug-resistant HIV. Synonyms: N-[(1S,2S)-2-Hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]carbamic Acid 1,1-Dimethylethyl Ester. Grade: > 95%. CAS No. 1133153-38-4. Molecular formula: C25H35N3O7S. Mole weight: 521.63. | |
| DO264 | DO264 is a potent, selective, and in vivo active ABHD12 inhibitor. DO264 inhibits ABHD12 and increases lyso-PS content in human monocytic cells. Synonyms: DO-264; DO 264; 1-(1-(3-Chloro-4-(2-chloro-4-(trifluoromethoxy)phenoxy)pyridin-2-yl)piperidin-4-yl)-3-(pyridin-3-yl)thiourea. Grade: 99%. CAS No. 2301866-59-9. Molecular formula: C23H20Cl2F3N5O2S. Mole weight: 558.40. | |
| DO2A | DO2A is an impurity of Gadoteridol. Gadoterido is a gadolinium-based MRI contrast agent. It is sold under the brand name ProHance. Grade: > 95%. Molecular formula: C12H24N4O4. Mole weight: 288.34. | |
| DO2A-tert-butyl ester | DO2A-tert-butyl ester is a bifunctional chelator ( BFC ) that can be used for the coupling of peptides and radionuclides. DO2A-tert-butyl ester can be used in the development of radionuclide imaging tracers [1]. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 162148-48-3. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W283556. |  |
| DO34 | DO34 is a highly potent, selective and centrally active diacylglycerol lipase (DAGL) inhibitor, with an IC50 of 6 nM for DAGL? conversion of SAG to 2-AG, and an IC50 for DAGL?. Uses: Scientific research. Group: Signaling pathways. CAS No. 1848233-58-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-117771. | |
| DO3A tert-Butyl ester | DOTA tert-Butyl ester is a benxyl derivative of the cyclic tosamide; can be nitrated directly; is more convenient to incorporate the nitro group after deprotection lithium aluminum hydride. Synonyms: Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7-triacetate; DO3A-t-Bu-ester; 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic Acid Tri-tert-butyl Ester. Grade: >98%. CAS No. 122555-91-3. Molecular formula: C26H50N4O6. Mole weight: 514.70. | |
| DOB-41 | DOB-41 is produced by the strain of Pseudomonas DOB-41. It has strong anti-gram-positive bacteria activity, and has the effect of inhibiting tumor. It prolongs the survival of transplanted leukemia P388 mice. Synonyms: Dob-41 antibiotic; Antibiotic dob 41; 6-[(R)-1-[(R)-3-Hydroxy-2-methoxy-1-oxopropoxy]ethyl]-1-phenazinecarboxylic acid. CAS No. 115666-98-3. Molecular formula: C19H18N2O6. Mole weight: 370.36. | |
| Dobesilate Calcium | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| Dobutamine | Dobutamine is a catecholamine used to treat heart failure by inhibiting β1 receptors in the sympathetic nervous system. Uses: Β1- and β2-adrenoceptor agonist with some action at the α1-adrenoceptor. Synonyms: Dobutamina; Dobutrex; (RS)-4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol; (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol. Grade: ≥98%. CAS No. 34368-04-2. Molecular formula: C18H23NO3. Mole weight: 301.38. | |
| Dobutamine-D4 Hydrochloride | Dobutamine-D4 Hydrochloride. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1246815-74-6. Molecular formula: C18H20ClD4NO3. Mole weight: 341.87. Catalog: APB1246815746. | |
| Dobutamine hydrochloride | β1- and β2-adrenoceptor agonist with some action at the α1-adrenoceptor. Group: Biochemicals. Alternative Names: 4- [2- [ [3- (4-Hydroxyphenyl) -1-methylpropyl] aminoethyl-1, 2-benzenediol hydrochloride. Grades: Highly Purified. CAS No. 49745-95-1. Pack Sizes: 50mg. Molecular Formula: C18H23NO3.HCl, Molecular Weight: 337.85. US Biological Life Sciences. |  Worldwide |
| Dobutamine hydrochloride | Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors of the sympathetic nervous system. Synonyms: 4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol hydrochloride; LY 81929; LY-81929; LY81929; Dobutamine; Dobutamina. Grade: >98%. CAS No. 49745-95-1. Molecular formula: C18H24ClNO3. Mole weight: 337.84. | |
| Dobutamine hydrochloride | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C18H23NO3 · HCl. CAS No. 49745-95-1. Prepack ID 23656097-1g. Molecular Weight 337.84. See USA prepack pricing. |  |
| Dobutamine hydrochloride | Dobutamine hydrochloride is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine hydrochloride is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion [1] [2] [3] [4]. Uses: Scientific research. Group: Signaling pathways. CAS No. 49745-95-1. Pack Sizes: 10 mM * 1 mL; 100 mg. Product ID: HY-15746. | |
| Dobutamine hydrochloride | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C18H23NO3 · HCl. CAS No. 49745-95-1. Prepack ID 23656097-100mg. Molecular Weight 337.84. See USA prepack pricing. | |
| Dobutamine Hydrochloride | ?98%. Group: Fluorescence/luminescence spectroscopyapi standardsbritish pharmacopoeiaeuropean pharmacopoeia (ph. eur.)pharmaceutical toxicologypharmacopoeial standards. Alternative Names: Inotrex, (RS)-4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]benzene-1,2-diol hydrochloride, Dobutamine hydrochloride, Dobutrex,Dobutamine hydrochloride, NSC 299583, dl-Dobutamine hydrochloride, 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (9CI), 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1), DL-Dobutamine hydrochloride. | |
| Dobutamine Hydrochloride | Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors of the sympathetic nervous system. Alternative Names: Dobutamine Hcl. Dobutrex. Inotrex. CAS No. 49745-95-1. Product ID: API49745951. Molecular formula: C18H24ClNO3. Mole weight: 337.8. EINECS: 256-464-1. SMILES: CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl. Appearance: Grey Solid. Standard: USP/EP/BP/JP. Category: APIs for Chronic Cardiac Insufficiency. |  |
| Dobutamine Impurity 32 | Dobutamine Impurity 32. Uses: For analytical and research use. Group: Impurity standards. CAS No. 14165-67-4. Molecular formula: C17H21NO4S. Mole weight: 335.42. Catalog: APB14165674. | |
| Dobutamine Impurity 4 | Dobutamine Impurity 4. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-(3-{[2-(3,4-dimethoxyphenyl)ethyl]amino}butyl)phenol. CAS No. 140165-60-2. Molecular formula: C20H27NO3. Mole weight: 329.43. Catalog: APB140165602. | |
| Dobutamine Impurity C HCl | A trimethoxy precursor and impurity of Dobutamine. Synonyms: N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxy-α-methylbenzenepropanamine Hydrochloride; Trimethoxydobutamine Hydrochloride. Grade: > 95%. CAS No. 51062-14-7. Molecular formula: C21H29NO3·HCl. Mole weight: 379.92. | |
| Dobutamine Impurity E | Dobutamine Impurity E. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-(4-methoxyphenyl)butan-2-one. CAS No. 104-20-1. Molecular formula: C11H14O2. Mole weight: 178.23. Catalog: APB104201. | |
| Docetaxal | Docetaxal. Group: Biochemicals. Alternative Names: (αR, βS)- β - [ [ (1, 1-Dimethylethoxy) carbonyl] amino] - α -hydroxy Benzene propanoic Acid (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-6, 12b-Bis(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4, 11-dihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester; 10-Acetyldocetaxel; 10-Acetyltaxotere; PNU 101383. Grades: Highly Purified. CAS No. 125354-16-7. Pack Sizes: 5mg. Molecular Formula: C45H55NO15, Molecular Weight: 849.92. US Biological Life Sciences. | Worldwide |
| Docetaxal | Docetaxal (10-Acetyl docetaxel) is an analog of Docetaxel (HY-B0011), with anticancer activity. Docetaxel is a microtubule disassembly inhibitor, with antimitotic activity [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: 10-Acetyl docetaxel; PNU-101383. CAS No. 125354-16-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0018. | |
| Docetaxal-d9 | Docetaxal-d9. Group: Biochemicals. Alternative Names: (αR, βS)- β - [ [ (1, 1-Dimethylethoxy) carbonyl] amino] - α -hydroxy Benzene propanoic Acid (2aR, 4S, 4aS, 6R, 9S, 11S, 12S, 12aR, 12bS)-6, 12b-Bis(acetyloxy)-12-(benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-4, 11-dihydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester-d9; 10-Acetyldocetaxel-d9; 10-Acetyltaxotere-d9; PNU 101383-d9. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C45H46D9NO15, Molecular Weight: 858.97. US Biological Life Sciences. | Worldwide |
| Docetaxel | Docetaxel anhydrous is a Microtubule Inhibitor. The physiologic effect of docetaxel anhydrous is by means of Microtubule Inhibition. Alternative Names: Taxotere. Docetaxel anhydrous. Docetaxol. CAS No. 114977-28-5. Product ID: API114977285. Molecular formula: C43H53NO14. Mole weight: 807.9. SMILES: CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O. Appearance: White solid. Category: Anti-Tumor APIs. | |
| Docetaxel | An antineoplastic. An antimitotic agent that promotes the assembly of microtublules and inhibits their depolymerization to free tubulin. Docetaxel is of the chemotherapy drug class; taxane, and is a semi-synthetic analogue of paclitaxel (Taxol), an extract from the bark of the rare Pacific yew tree Taxus brevifolia. Due to scarcity of paclitaxel, extensive research was carried out leading to the formulation of docetaxel - an esterified product of 10-deacetyl baccatin III, which is extracted from the renewable and more readily available leaves of the European yew tree. Group: Biochemicals. Alternative Names: Docecad; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; Taxoltere metro; docetaxol; Taxotere. Grades: Highly Purified. CAS No. 114977-28-5. Pack Sizes: 100mg, 500mg, 1g. US Biological Life Sciences. | Worldwide |
| Docetaxel | purum, ?97.0% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Docetaxel | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C43H53NO14. CAS No. 114977-28-5. Prepack ID 75180981-1g. Molecular Weight 807.88. See USA prepack pricing. | |
| Docetaxel | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C43H53NO14. CAS No. 114977-28-5. Prepack ID 75180981-100mg. Molecular Weight 807.88. See USA prepack pricing. | |
| Docetaxel | 500mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C43H53NO14. CAS No. 114977-28-5. Prepack ID 75180981-500mg. Molecular Weight 807.88. See USA prepack pricing. | |
| Docetaxel | Docetaxel (RP-56976) is a microtubule depolymerization inhibitor, with an IC 50 of 0.2 μM. Docetaxel attenuates the effects of bcl-2 and bcl-xL gene expression. Docetaxel arrests the cell cycle at G2/M and leads to cell apoptosis. Docetaxel has anti-cancer activity [1] [3]. Uses: Scientific research. Group: Natural products. Alternative Names: RP-56976. CAS No. 114977-28-5. Pack Sizes: 10 mM * 1 mL; 100 mg; 200 mg; 500 mg. Product ID: HY-B0011. | |
| Docetaxel | Docetaxel, also called Taxoltere metro, a semisynthetic side-chain analogue of taxol differing at two positions in its chemical structure, is an inhibitior of microtubule disassembly (IC50 = 0.2 μM). And it inhibits cell replication (IC50 = 0.13 μM). Uses: Antitumor. Synonyms: docetaxel; docetaxel anhydrous; docetaxel hydrate; docetaxel trihydrate; docetaxol; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol; NSC 628503; RP 56976; RP-56976; Taxoltere metro; 114977-28-5. Grade: 98%~102%. CAS No. 114977-28-5. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| Docetaxel | Docetaxel (RP-56976) is a microtubule depolymerization inhibitor, with an IC50 of 0.2 μM. Docetaxel attenuates the effects of bcl-2 and bcl-xL gene expression. Docetaxel arrests the cell cycle at G2/M and leads to cell apoptosis. Docetaxel has anti-cancer activity. Uses: Designed for use in research and industrial production. Additional or Alternative Names: TAXOTERE;n-debenzoyl-n-tert-butoxycarbonyl-10-deacetyl taxol;)benz(1,2-b)oxet-9-ylester,(2ar-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alph;-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydr;benzenepropanoicacid,beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy;beta-s*),11-alpha,12-alpha,12a-alpha,12b-alpha))-a-r;o-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4;rp56976. Product Category: Inhibitors. Appearance: Solid. CAS No. 114977-28-5. Molecular formula: C43H53NO14. Mole weight: 807.88. Purity: 0.9942. Canonical SMILES: O=C(OC(C)(C)C)N[C@@H](C1=CC=CC=C1)[C@H](C(O[C@@H]2C(C)=C([C@@H](O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@@]4([H])C[C@@H]3O)([H])[C@@H]5OC(C6=CC=CC=C6)=O)=O)C(C)(C)[C@@]5(O)C2)=O)O. Product ID: ACM114977285-1. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Docetaxel 2',7,10-Tris(triethylsilyl) Ether | Docetaxel 2',7,10-Tris(triethylsilyl) Ether is a derivative of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 2',7,10-Tris(triethylsilyl)docetaxel; [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-[(triethylsilyl)oxy]-benzenepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[(triethylsilyl)oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester; (2α,5β,7β,10β,13α)-4-Acetoxy-1-hydroxy-13-({(2R,3S)-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenyl-2-[(triethylsilyl)oxy]propanoyl}oxy)-9-oxo-7,10-bis[(triethylsilyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate. Grade: ≥95%. CAS No. 149107-86-8. Molecular formula: C61H95NO14Si3. Mole weight: 1150.66. | |
| Docetaxel 2',7,10-Tris(triethylsilyl) Ether | Used in the preparation of Paclitaxel (P132500) derivatives. Group: Biochemicals. Alternative Names: 2', 7, 10-Tris (triethylsilyl) docetaxel; [2aR-[2aα,4 β,4a β,6 β, 9α(αR*, βS*), 11α, 12α, 12aα, 12bα]]- β -[[ (1, 1-Dimethylethoxy) carbonyl]amino]-α -[ (triethylsilyl) oxy]-benzenepropanoic Acid 12b- (Acetyloxy)-12- (benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-11-hydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-4, 6-bis[ (triethylsilyl)oxy]-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester. Grades: Highly Purified. CAS No. 149107-86-8. Pack Sizes: 2.5mg. US Biological Life Sciences. | Worldwide |
| Docetaxel Crotonaldehyde Analog | Docetaxel Crotonaldehyde Analog. Uses: For analytical and research use. Group: Impurity standards. Catalog: APS001574. Format: Neat. | |
| Docetaxel Crotonaldehyde Analog | Docetaxel Crotonaldehyde Analog is an impurity of Docetaxel. Grade: > 95%. Molecular formula: C43H51NO14. Mole weight: 805.86. | |
| Docetaxel-d5 | A labeled semisynthetic derivative of Paclitaxel. An antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. An antineoplastic. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Docetaxel-d5 2',7,10-Tris(triethylsilyl) Ether | Used in the preparation of Paclitaxel (P132500) derivatives. Group: Biochemicals. Alternative Names: 2', 7, 10-Tris (triethylsilyl) docetaxel-d5; [2aR-[2aα,4 β,4a β,6 β, 9α(αR*, βS*), 11α, 12α, 12aα, 12bα]]- β -[[ (1, 1-Dimethylethoxy) carbonyl]amino]-α -[ (triethylsilyl) oxy]-benzenepropanoic-d5 Acid 12b- (Acetyloxy)-12- (benzoyloxy)-2a, 3, 4, 4a, 5, 6, 9, 10, 11, 12, 12a, 12b-dodecahydro-11-hydroxy-4a, 8, 13, 13-tetramethyl-5-oxo-4, 6-bis[ (triethylsilyl)oxy]-7, 11-methano-1H-cyclodeca[3, 4]benz[1, 2-b]oxet-9-yl Ester. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Docetaxel-d6 Metabolites M1 and M3 (Mixture of Diastereomers) | The major labeled metabolites 1 and 3 (diastereomers) of Docetaxel. Group: Biochemicals. Alternative Names: RPR 111026-d6. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Docetaxel-d9 | Docetaxel-d9 is the deuterium labeled Docetaxel. Docetaxel (RP-56976) is a microtubule depolymerization inhibitor, with an IC50 of 0.2 μM. Docetaxel attenuates the effects of bcl-2 and bcl-xL gene expression. Docetaxel arrests the cell cycle at G2/M and leads to cell apoptosis. Docetaxel has anti-cancer activity. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Docetaxel-D9;Taxotere-d9;Docetaxol-d9;N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol-d9;RP 56976-d9;DOCETAXEL, d9-(SH). Product Category: Inhibitors. Appearance: White Solid. CAS No. 940867-25-4. Molecular formula: C43H44D9NO14. Mole weight: 816.93. Canonical SMILES: CC(O[C@]12[C@@]3([H])[C@@H]([C@]4(C(C)(C([C@H](C([C@@]3([C@H](C[C@@]1([H])OC2)O)C)=O)O)=C([C@H](C4)OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)=O)C)C)O)OC(C6=CC=CC=C6)=O)=O. Product ID: ACM940867254. Alfa Chemistry ISO 9001:2015 Certified. | |
| Docetaxel-[d9] | Docetaxel-[d9] is the labelled analogue of Docetaxel. Docetaxel is a chemotherapy medication used to treat a number of types of cancer. Synonyms: Docetaxel D9. Grade: 95% by HPLC; 95% atom D. CAS No. 940867-25-4. Molecular formula: C43H44D9NO14. Mole weight: 816.93. | |
| Docetaxel-d9 (Taxotere-d9) | An antineoplastic. An antimitotic agent that promotes the assembly of microtublules and inhibits their depolymerization to free tubulin. Group: Biochemicals. Grades: Highly Purified. CAS No. 940867-25-4. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Docetaxel EP Impurity A | Docetaxel EP Impurity A is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 2-O-desbenzoyl-2-O-tiglyldocetaxel; 5β,20-epoxy-1,7β,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] 2-[(2E)-2-methylbut-2-enoate]. CAS No. 1887057-05-7. Molecular formula: C41H55NO14. Mole weight: 785.87. | |
| Docetaxel EP Impurity B | A novel taxoid having remarkable anti-tumor properties. Docetaxel intermediate. This product is unstable in solution, epimerize. Synonyms: 6-Oxo Docetaxel (USP); 10-Oxo Docetaxel; 10-Deoxy-10-Oxo Docetaxel; 5β,20-Epoxy-1,7β-dihydroxy-9,10-dioxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] (as per EP); (2aR,4S,4aS,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,9,11,12,12b-pentahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5,6-dione 12b-acetate, 12-benzoate, 9-ester. Grade: >98%. CAS No. 167074-97-7. Molecular formula: C43H51NO14. Mole weight: 805.86. | |
| Docetaxel EP Impurity B | Docetaxel EP Impurity B. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 10-deoxy-10-oxodocetaxel; (2aR,4S,4aS,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5,6-dioxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 167074-97-7. Molecular formula: C43H51NO14. Mole weight: 805.86. Catalog: APB167074977. | |
| Docetaxel EP Impurity C | Docetaxel EP Impurity C is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 4-epi-Docetaxel (USP); 4-Epidocetaxel; 7-Epidocetaxel; 7-Epitaxotere; 5β,20-epoxy-1,7α,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate]. Grade: >98%. CAS No. 153381-68-1. Molecular formula: C43H53NO14. Mole weight: 807.88. | |
| Docetaxel EP Impurity C | Docetaxel EP Impurity C. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7-epi-Docetaxel; (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 153381-68-1. Molecular formula: C43H53NO14. Mole weight: 807.88. Catalog: APB153381681. | |
| Docetaxel EP Impurity D | Docetaxel EP Impurity D is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 4-Epi-6-Oxo Docetaxel (USP); 10-Deoxy-10-Oxo-7-epi-Docetaxel; 4-epi-6-Oxodocetaxel; 5β,20-Epoxy-1,7α-dihydroxy-9,10-dioxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate]. Grade: >98%. CAS No. 162784-72-7. Molecular formula: C43H51NO14. Mole weight: 805.86. | |
| Docetaxel EP Impurity G | Docetaxel EP Impurity G. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate. CAS No. 125354-16-7. Molecular formula: C45H55NO15. Mole weight: 849.92. Catalog: APB125354167. | |
| Docetaxel EP Impurity G | Docetaxel EP Impurity G is an impurity of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: 10-Acetyl Docetaxel (EP); Docetaxal; N-Debenzoyl-N-(tert-butoxycarbonyl)taxol; 5β,20-Epoxy-1,7β-dihydroxy-9-oxotax-11-ene-2α,4,10β,13α-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-henylpropanoate]. Grade: > 95%. CAS No. 125354-16-7. Molecular formula: C45H55NO15. Mole weight: 849.94. | |
| Docetaxel Hydrate | Docetaxel Hydrate, a semisynthetic derivative of Paclitaxel, is used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Uses: A semisynthetic derivative of paclitaxel. an antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. an antineoplastic. Synonyms: (αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester Hydrate; N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Hydrate; RP 56976 Hydrate; Taxotere Hydrate. CAS No. 700367-34-6. Molecular formula: C43H53NO14.xH2O. Mole weight: 807.88 (anhydrous). | |
| Docetaxel Hydrate | A semisynthetic derivative of Paclitaxel. An antimitotic agent that promotes the assembly of micro-tubules and inhibits their de-polymerization to free tubulin. An antine oplastic. Group: Biochemicals. Grades: Highly Purified. CAS No. 700367-34-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Docetaxel Hydroxy tert-Butylcarbamate | Docetaxel Hydroxy tert-Butylcarbamate is a metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: Docetaxel Metabolite M2; RPR-104952; Benzenepropanoic acid, α-hydroxy-β-[[(2-hydroxy-1,1-dimethylethoxy)carbonyl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; (2α,5β,7β,10β,13α)-4-Acetoxy-1,7,10-trihydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(1-hydroxy-2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxytax-11-en-2-yl benzoate. Grade: ≥95%. CAS No. 154044-57-2. Molecular formula: C43H53NO15. Mole weight: 823.88. | |
| Docetaxel Hydroxy tert-Butylcarbamate | The main metabolite of Docetaxel (D494420), an antineoplastic. Group: Biochemicals. Grades: Highly Purified. CAS No. 154044-57-2. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Docetaxel Impurity 1 | A metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: (αR,βS)-β-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-6-[[(2,2-dichloroethoxy)carbonyl]oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,1. Grade: > 95%. CAS No. 158810-73-2. Molecular formula: C46H55Cl2NO16. Mole weight: 948.83. | |
| Docetaxel Impurity 11 | Docetaxel Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-Debenzoyl-2-Pentenoyl Docetaxel; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl pent-4-enoate. CAS No. 1412898-66-8. Molecular formula: C41H55NO14. Mole weight: 785.87. Catalog: APB1412898668. | |
| Docetaxel Impurity 15 | Docetaxel Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2R,3S)-methyl 3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoate. CAS No. 124605-42-1. Molecular formula: C15H21NO5. Mole weight: 295.33. Catalog: APB124605421. | |
| Docetaxel Impurity 17 | Docetaxel Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (2aR,4R,4aS,9S,11S,12S,12aR,12bS)-12b-acetoxy-4,9,11-trihydroxy-4a,8,13,13-tetramethyl-5,6-dioxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl benzoate. CAS No. 151636-94-1. Molecular formula: C29H34O10. Mole weight: 542.57. Catalog: APB151636941. | |
| Docetaxel Impurity 18 | Docetaxel Impurity 18. Uses: For analytical and research use. Group: Impurity standards. CAS No. 154084-01-2. Molecular formula: C43H53NO15. Mole weight: 823.89. Catalog: APB154084012. | |
| Docetaxel Impurity 19 | Docetaxel Impurity 19 is an impurity of Docetaxel, a chemotherapy drug used to treat a variety of cancers. CAS No. 92950-45-3. Molecular formula: C29H34O10. Mole weight: 542.58. | |
| Docetaxel Impurity 19 | Docetaxel Impurity 19. Uses: For analytical and research use. Group: Impurity standards. CAS No. 154044-57-2. Molecular formula: C43H53NO15. Mole weight: 823.89. Catalog: APB154044572. | |
| Docetaxel Impurity 2 | A metabolite of Docetaxel, which is a semisynthetic derivative of Paclitaxel used to treat a variety of cancers, including breast, head and neck, stomach, prostate, and non-small cell lung cancer. Synonyms: Benzenepropanoic acid, -[[(1,1-dimethylethoxy)carbonyl]amino]--hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-4-[[(2,2-dichloroethoxy)carbonyl]oxy]-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-6,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (R,S)-. Grade: > 95%. CAS No. 158810-72-1. Molecular formula: C46H55Cl2NO16. Mole weight: 948.83. | |
Our database is helping our users find suppliers everyday.
